Ryan Watts
Founder at DENALI THERAPEUTICS INC.
Net worth: 50 M $ as of 30/03/2024
Profile
Dr. Ryan J. Watts is a President, Chief Executive Officer & Director at Denali Therapeutics, Inc. He is on the Board of Directors at Denali Therapeutics, Inc. Dr. Watts was previously employed as a Director-Neuroscience Department by Genentech, Inc. He received his undergraduate degree from the University of Utah and a doctorate degree from Stanford University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DENALI THERAPEUTICS INC.
1.75% | 28/03/2024 | 2,440,671 ( 1.75% ) | 50 M $ | 30/03/2024 |
Ryan Watts active positions
| Companies | Position | Start |
|---|---|---|
| DENALI THERAPEUTICS INC. | Founder | 13/10/2013 |
Peel Therapeutics, Inc.
 Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Director/Board Member | 22/02/2023 |
Former positions of Ryan Watts
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Founder | 31/01/2015 |
Training of Ryan Watts
| Stanford University | Doctorate Degree |
| University of Utah | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Ryan Watts
